4.6 Article

Rad9, Rad17, TopBP1 and Claspin Play Essential Roles in Heat-Induced Activation of ATR Kinase and Heat Tolerance

Journal

PLOS ONE
Volume 8, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0055361

Keywords

-

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Science and Technology Incubation Program in Advanced Regions
  3. Japan Science and Technology Agency
  4. Grants-in-Aid for Scientific Research [24701028, 25460390] Funding Source: KAKEN

Ask authors/readers for more resources

Hyperthermia is widely used to treat patients with cancer, especially in combination with other treatments such as radiation therapy. Heat treatment per se activates DNA damage responses mediated by the ATR-Chk1 and ATM-Chk2 pathways but it is not fully understood how these DNA damage responses are activated and affect heat tolerance. By performing a genetic analysis of human HeLa cells and chicken B lymphoma DT40 cells, we found that heat-induced Chk1 Ser345 phosphorylation by ATR was largely dependent on Rad9, Rad17, TopBP1 and Claspin. Activation of the ATR-Chk1 pathway by heat, however, was not associated with FancD2 monoubiquitination or RPA32 phosphorylation, which are known as downstream events of ATR kinase activation when replication forks are stalled. Downregulation of ATR, Rad9, Rad17, TopBP1 or Claspin drastically reduced clonogenic cell viability upon hyperthermia, while gene knockout or inhibition of ATM kinase reduced clonogenic viability only modestly. Suppression of the ATR-Chk1 pathway activation enhanced heat-induced phosphorylation of Chk2 Thr68 and simultaneous inhibition of ATR and ATM kinases rendered severe heat cytotoxicity. These data indicate that essential factors for activation of the ATR-Chk1 pathway at stalled replication forks are also required for heat-induced activation of ATR kinase, which predominantly contributes to heat tolerance in a non-overlapping manner with ATM kinase.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer

Yumiko Kinoshita, Rieko Izukura, Junji Kishimoto, Maki Kanaoka, Hayato Fujita, Koji Ando, Shuntaro Nagai, Sayuri Akiyoshi, Tetsuzo Tagawa, Makoto Kubo, Junichi Inokuchi, Kenoki Ohuchida, Eiji Oki, Kentaro Tanaka, Masatoshi Eto, Tomoharu Yoshizumi, Masafumi Nakamura, Akiko Chishaki

Summary: This study assessed the reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 questionnaire for evaluating the health-related quality of life in elderly Japanese patients with cancer. The results showed that the questionnaire has acceptable reliability and validity in this population.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Artificial Intelligence-Based Prediction of Recurrence After Curative Resection for Colorectal Cancer From Digital Pathological Images

R. Nakanishi, K. Morooka, K. Omori

DISEASES OF THE COLON & RECTUM (2023)

Editorial Material Oncology

Artificial Intelligence-Based Prediction of Recurrence After Curative Resection for Colorectal Cancer From a Digital Pathologic Image

Ryota Nakanishi, Ken'ichi Morooka, Kazuki Omori, Satoshi Toyota, Yasushi Tanaka, Hirofumi Hasuda, Naomichi Koga, Kentaro Nonaka, Qingjiang Hu, Yu Nakaji, Tomonori Nakanoko, Koji Ando, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi

ANNALS OF SURGICAL ONCOLOGY (2023)

Review Oncology

Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan

Seiya Sato, Yoshiaki Nakamura, Eiji Oki, Takayuki Yoshino

Summary: The body of evidence supporting the utility of ctDNA analysis for detecting MRD in resected CRC is rapidly growing, leading to the development of escalation and de-escalation ACT strategies. The CIRCULATE-Japan project is one of the largest randomized clinical trials investigating this approach. This review provides an overview of the potential utility of ctDNA-based MRD detection for guiding ACT in patients with resected CRC, with a focus on the findings from the CIRCULATE-Japan project.

CLINICAL COLORECTAL CANCER (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Extracellular volume fraction determined by equilibrium contrast-enhanced computed tomography: correlation with histopathological findings in gastric cancer

Yusuke Nishimuta, Daisuke Tsurumaru, Satohiro Kai, Junki Maehara, Yoshiki Asayama, Eiji Oki, Kousei Ishigami

Summary: This study aims to assess the correlation between histopathological features of gastric cancer and the extracellular volume fraction (ECV) measured by preoperative equilibrium contrast-enhanced computed tomography (CECT). The results showed that the values of venous invasion and tumor infiltration pattern were significantly correlated with tumor ECV. Linear regression and receiver operating characteristic (ROC) curve analyses further confirmed the correlation between tumor ECV and pathological infiltration. The tumor ECV demonstrated high diagnostic accuracy for predicting infiltration.

JAPANESE JOURNAL OF RADIOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients

Eiji Shinto, Eiji Oki, Mototsugu Shimokawa, Shigeki Yamaguchi, Megumi Ishiguro, Seiji Hasegawa, Yasumasa Takii, Hideyuki Ishida, Tetsuya Kusumoto, Masaru Morita, Naohiro Tomita, Manabu Shiozawa, Masafumi Tanaka, Heita Ozawa, Yojiro Hashiguchi, Shinobu Ohnuma, Sachiyo Tada, Tomoko Matsushima, Keisuke Yamagishi, Kazuo Hase

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients

Eiji Shinto, Eiji Oki, Mototsugu Shimokawa, Shigeki Yamaguchi, Megumi Ishiguro, Seiji Hasegawa, Yasumasa Takii, Hideyuki Ishida, Tetsuya Kusumoto, Masaru Morita, Naohiro Tomita, Manabu Shiozawa, Masafumi Tanaka, Heita Ozawa, Yojiro Hashiguchi, Shinobu Ohnuma, Sachiyo Tada, Tomoko Matsushima, Keisuke Yamagishi, Kazuo Hase

Summary: This study confirmed the predictive power of the MBS for recurrence risk in stage II/III CC patients by using FFPE materials. The MBS-low group demonstrated better relapse-free survival compared with the MBS-high group, and the MBS score was found to be an independent prognostic factor.

ANNALS OF SURGICAL ONCOLOGY (2023)

Review Oncology

Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review

Sachie Omori, Tomoko Shigechi, Kana Kawaguchi, Hideki Ijichi, Eiji Oki, Tomoharu Yoshizumi

Summary: TLS in solid tumors is a life-threatening condition that can be complicated by DIC. Early recognition and treatment of patients at risk of TLS is crucial to prevent fatal situations. This case report and literature review focuses on identifying the distinctive features and hazards of TLS in breast cancer.

ANTICANCER RESEARCH (2023)

Article Surgery

Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations

Eiji Oki, Mitsuhiko Ota, Tomonori Nakanoko, Yasushi Tanaka, Satoshi Toyota, Qingjiang Hu, Yu Nakaji, Ryota Nakanishi, Koji Ando, Yasue Kimura, Yuichi Hisamatsu, Koshi Mimori, Yoshiya Takahashi, Hajime Morohashi, Takahiro Kanno, Kotaro Tadano, Kenji Kawashima, Hironobu Takano, Yuma Ebihara, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto, Tomoharu Yoshizumi, Kenichi Hakamada, Satoshi Hirano, Masaki Mori

Summary: This study describes the first application of a double-surgeon cockpit system to telesurgery. Non-specialized surgeons were able to safely perform cholecystectomy and renal vein ligation with remote assistance using the system, and the system also received higher technical scores compared to telesurgery performed by specialized surgeons.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

Article Oncology

NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases

Shin Kobayashi, Hideaki Bando, Akinobu Taketomi, Takeshi Takamoto, Eiji Shinozaki, Manabu Shiozawa, Hiroki Hara, Kentaro Yamazaki, Koji Komori, Nobuhisa Matsuhashi, Takeshi Kato, Yoshinori Kagawa, Mitsuru Yokota, Eiji Oki, Keigo Komine, Shinichiro Takahashi, Masashi Wakabayashi, Takayuki Yoshino

Summary: This study aims to evaluate the efficacy and safety of a novel triplet regimen in the perioperative period for patients with resectable BRAF V600E mutant colorectal cancer. The triplet regimen includes encorafenib, binimetinib, and cetuximab, administered for 3 cycles each before and after curative resection. The primary endpoint is the 1-year progression-free survival rate, and secondary endpoints include disease-free survival, overall survival, and objective response rate.

BMC CANCER (2023)

Article Oncology

Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)

Koji Ando, Yoshiaki Nakamura, Hiroyuki Kitao, Mototsugu Shimokawa, Daisuke Kotani, Hideaki Bando, Tomohiro Nishina, Takanobu Yamada, Satoshi Yuki, Yukiya Narita, Hiroki Hara, Takashi Ohta, Taito Esaki, Yasuo Hamamoto, Ken Kato, Yoshiyuki Yamamoto, Keiko Minashi, Koushiro Ohtsubo, Naoki Izawa, Hisato Kawakami, Takeshi Kato, Taroh Satoh, Naohiro Okano, Akihito Tsuji, Kentaro Yamazaki, Takayuki Yoshino, Yoshihiko Maehara, Eiji Oki

Summary: This study evaluated the impact of TP53 gene mutation on the efficacy of Nivolumab treatment in gastric cancer patients and found that TP53 wild type patients had a higher objective response rate than mutant patients, and among mutant patients, the frameshift type had the highest response rate.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report

Shinichiro Ikeda, Qingjiang Hu, Keita Natsugoe, Tomoya Harima, Yasushi Tanaka, Izumi Kinoshita, Kentaro Nonaka, Sho Nambara, Ryota Nakanishi, Tomonori Nakanoko, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi

Summary: This case report describes a rare case of primary adenocarcinoma of the duodenum with high microsatellite instability (MSI-H). The patient was diagnosed with Lynch syndrome, which is closely related to MSI-H. Pembrolizumab therapy was effective in treating the tumor.

INTERNATIONAL CANCER CONFERENCE JOURNAL (2023)

Proceedings Paper Computer Science, Hardware & Architecture

MHND: Multi-Homing Network Design Model for Delay Sensitive Distributed Processing Applications

Akio Kawabata, Bijoy Chand Chatterjee, Eiji Oki

Summary: This paper proposes a multi-homing network design model named MHND, which balances low delay and high availability for distributed processing applications. MHND maintains event occurrence order using conservative synchronization and formulates an integer linear programming problem to minimize delay. Numerical results show that increasing the number of multi-homing servers improves availability but also increases delay. Two or more multi-homing can achieve approximately 10 times higher availability compared to single-homing at the cost of a 1.25 times delay increase. MHND enables flexible network design based on required availability and acceptable delay.

2023 IEEE 20TH CONSUMER COMMUNICATIONS & NETWORKING CONFERENCE, CCNC (2023)

Article Biochemistry & Molecular Biology

Postoperative circulating tumor DNA could guide CRC adjuvant treatment

Eiji Oki, Takayuki Yoshino

Summary: The ongoing CIRCULATE-Japan trial is investigating the role of ctDNA-based molecular residual disease testing in patients with resectable colorectal cancer after surgery. An interim analysis of GALAXY, a prospective observational arm, confirms ctDNA as a prognostic and predictive biomarker.

NATURE MEDICINE (2023)

Article Surgery

Technical evaluation of robotic tele-cholecystectomy: a randomized single-blind controlled pilot study

Yuma Ebihara, Satoshi Hirano, Hironobu Takano, Takahiro Kanno, Kenji Kawashima, Hajime Morohashi, Eiji Oki, Kenichi Hakamada, Shigeo Urushidani, Masaki Mori

Summary: This study evaluated the performance of robotic tele-cholecystectomy using the Saroa(TM) system. The results showed that there was no significant difference in completion time, technical assessment, and fatigue between tele-cholecystectomy and local surgery, but the total path length of the forceps was longer in tele-cholecystectomy.

JOURNAL OF ROBOTIC SURGERY (2023)

No Data Available